A comparison of the prognosis between the 1991 database and the current study
| . | 1991 database4 (1983-1987) . | Current study (2000-2009) . | ||
|---|---|---|---|---|
| Total . | Without allo-HSCT . | With allo-HSCT . | ||
| Acute | ||||
| n | 465 | 895 | 717 | 178 |
| Mean age, years | 56.0 | 63 | 66 | 51 |
| MST, months | 6.2 | 8.3 | 6.7 | 14.0 |
| 4-year OS, % | 5.0 | 11.4 | 6.8 | 27.8 |
| Lymphoma | ||||
| n | 156 | 355 | 306 | 49 |
| Mean age, years | 59.2 | 66 | 69 | 53 |
| MST, months | 10.2 | 10.6 | 9.7 | 13.9 |
| 4-year OS, % | 5.7 | 16.2 | 13.7 | 32.3 |
| Chronic | ||||
| n | 152 | 187 | ||
| Mean age, years | 57.5 | 61 | ||
| MST, months | 24.3 | 31.5 | ||
| 4-year OS, % | 26.9 | 35.6 | ||
| Smoldering | ||||
| n | 45 | 157 | ||
| Mean age, years | 59.3 | 67 | ||
| MST, months | not reached | 55.0 | ||
| 4-year OS, % | 62.8 | 51.9 | ||
| . | 1991 database4 (1983-1987) . | Current study (2000-2009) . | ||
|---|---|---|---|---|
| Total . | Without allo-HSCT . | With allo-HSCT . | ||
| Acute | ||||
| n | 465 | 895 | 717 | 178 |
| Mean age, years | 56.0 | 63 | 66 | 51 |
| MST, months | 6.2 | 8.3 | 6.7 | 14.0 |
| 4-year OS, % | 5.0 | 11.4 | 6.8 | 27.8 |
| Lymphoma | ||||
| n | 156 | 355 | 306 | 49 |
| Mean age, years | 59.2 | 66 | 69 | 53 |
| MST, months | 10.2 | 10.6 | 9.7 | 13.9 |
| 4-year OS, % | 5.7 | 16.2 | 13.7 | 32.3 |
| Chronic | ||||
| n | 152 | 187 | ||
| Mean age, years | 57.5 | 61 | ||
| MST, months | 24.3 | 31.5 | ||
| 4-year OS, % | 26.9 | 35.6 | ||
| Smoldering | ||||
| n | 45 | 157 | ||
| Mean age, years | 59.3 | 67 | ||
| MST, months | not reached | 55.0 | ||
| 4-year OS, % | 62.8 | 51.9 | ||